Indication
Hemodialysis
10 clinical trials
13 products
Product
HSK36273Clinical trial
A Multi-center, Randomized, Open, Positive-controlled Two-stage Phase II Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy SubjectsStatus: Not yet recruiting, Estimated PCD: 2023-10-01
Product
HeparinClinical trial
Lumasiran in Hyperoxalaemic Patients on HaemodialysisStatus: Not yet recruiting, Estimated PCD: 2024-11-30
Product
LumasiranClinical trial
Efficacy, Safety and Pharmacokinetics of Tinzaparin During Slow Low Efficient Daily Dialysis in Intensive Care PatientsStatus: Recruiting, Estimated PCD: 2025-12-31
Product
TinzaparinClinical trial
Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers on the Occurrence of S. Aureus Infections in Hemodialysis PatientsStatus: Recruiting, Estimated PCD: 2024-10-01
Product
DecolonizationClinical trial
Albumin To Enhance Recovery After Acute Kidney Injury: A Multi-Centre, Randomized, Controlled TrialStatus: Recruiting, Estimated PCD: 2025-08-28
Product
20-25% AlbuminClinical trial
Effects of Variation of Sodium Dialysate in ICU Acute Kiney InjuryStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Comparison of the Effecta and Drawbacks of Heparin Versus Hirudin Drugs in Haemodialysis Patients in Assiut University HospitalsStatus: Not yet recruiting, Estimated PCD: 2025-09-01
Clinical trial
Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation - A Prospective, Randomized, Controlled, Open, Cross-over, Phase II, Single-center Pilot Study [BiPhox-Trial]Status: Completed, Estimated PCD: 2023-11-15
Product
CVVH with PhoxiliumProduct
CVVH with BiphozylClinical trial
The Effect of Increasing Post-Filter Ionized Target on the Efficacy of Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy in Intensive Care: a Multicenter Randomized Controlled Non-Inferiority TrialStatus: Recruiting, Estimated PCD: 2025-01-01
Product
CitrateClinical trial
Clinical Study to Compare The Safety and Possible Efficacy of Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular HemodialysisStatus: Not yet recruiting, Estimated PCD: 2024-10-01
Product
FexofenadineProduct
Gabapentin